Cost effectiveness of a protocol using palivizumab in preterm infants

Objective: The main objective was to evaluate the cost-effectiveness of protocol use of palivizumab in premature established by consensus in our Hospital comparing it based on the recommendations of various Scientific Societies. As a secondary objective risk factors and severity of hospitalized pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Farmacia Hospitalaria
Autors principals: Yolanda Hernández-Gago, Marina Lombardero-Pin, Casilda Ortega de la Cruz, Pablo A Maciuniak, Alicia Díez del Pino
Format: Artigo
Idioma:Inglês
Publicat: Sociedad Española de Farmacia Hospitalaria 2017
Matèries:
Medicina
Cost
Neonate
Premature
Palivizumab
effectiveness
Accés en línia:https://www.redalyc.org/articulo.oa?id=365962268003
https://www.redalyc.org/journal/3659/365962268003/
https://www.redalyc.org/journal/3659/365962268003/html/
https://www.redalyc.org/journal/3659/365962268003/365962268003.epub
https://www.redalyc.org/journal/3659/365962268003/movil
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars